Validation of smoking cessation self-reported by patients with chronic obstructive pulmonary disease

International Journal of General Medicine

Volumn 4, Issue , 2011, Pages 85-90

  Hilberink, Sander R ^a   Jacobs, Johanna E ^a   van Opstal, Sanne ^b   van der Weijden, Trudy ^b   Keegstra, Janine ^a   Kempers, Pascal L J ^b   Muris, Jean W M ^b   Grol, Richard P T M ^a   de Vries, Hein ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Biochemical validation; Chronic obstructive pulmonary disease; General practice; Outcome measurement; Smoking cessation

Indexed keywords

COTININE;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DOCTOR PATIENT RELATION; FEMALE; GENERAL PRACTICE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIMARY MEDICAL CARE; SELF REPORT; SENSITIVITY AND SPECIFICITY; SMOKING CESSATION; SMOKING CESSATION PROGRAM; URINALYSIS; VALIDATION PROCESS;

EID: 84897366713     PISSN: None     EISSN: 11787074     Source Type: Journal    
DOI: 10.2147/IJGM.S15231     Document Type: Article

References (32)

1. Stead LF, Bergson G, Lancaster T. Physician advice for smoking cessation. Cochrane Database Syst Rev. 2008;2:CD000165.
2. Pieterse ME, Seydel ER, Vries H de, Mudde AN, Kok GJ. Effectiveness of a minimal contact smoking cessation program for Dutch general practitioners: a randomized controlled trial. Prev Med. 2001;32(2): 182-190.
3. Zwar NA, Richmond RL. Role of the general practitioner in smoking cessation. Drug Alcohol Rev. 2006;25(1):21-26.
4. Coleman T, Murphy E, Cheater F. Factors influencing discussion of smoking between general practitioners and patients who smoke: a qualitative study. Brit J Gen Pract. 2000;50(452):207-210.
5. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD Executive Summary. Am J Respir Crit Care Med. 2007;176(6): 532-555.
6. Mannino DM. COPD: Epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest. 2002;121(5 Suppl):S121-S126.
7. Decramer M, Gosselink R, Bartsch P, et al. Effect of treatments on the progression of COPD: report of a workshop held in Leuven, 2004 March 11-12. Thorax. 2005;60(4):343-349.
8. Wouters EF. Economic analysis of the confronting COPD survey: an overview of results. Respir Med. 2003;97(Suppl C):S3-S14.
9. Scanlon PD, Connett JE, Waller LA, et al. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med. 2000;161(2 Pt 1): 381-390.
10. 1. The Lung Health Study. JAMA. 1994; 272(19):1497-1505.
11. Willemse BWM, Postma DS, Timens W, ten Hacken NH. The impact of smoking cessation on respiratory symptoms, lung function, hyperresponsiveness and inflammation. Eur Respir J. 2004;23(3): 464-476.
12. Hersh CP, DeMeo DL, Al-Ansari E, et al. Predictors of survival in severe, early onset COPD. Chest. 2004;126(5):1443-1451.
13. Velicer WF, Prochaska JO, Rossi JS, Snow MG. Assessing outcome in smoking cessation studies. Psychol Bull. 1992;111(1):23-41.
14. Wagenknecht LE, Burke GL, Perkins LL, Haley NJ, Friedman GD. Misclassification of smoking status in the CARDIA study: A comparison of self-report with serum cotinine levels. Am J Public Health. 1992;82(1):33-36.
15. Patrick DL, Cheadle A, Thompson MS, et al. The validity of selfreported smoking: A review and meta-analysis. Am J Public Health. 1994;84(7):1086-1093.
16. Pokorski TL, Chen WW, Bertholf RL. Use of urine cotinine to validate smoking self-reports in US navy recruits. Addict Behav. 1994;19(4): 451-454.
17. Klesges RC, Debon M, Ray JW. Are self-reports of smoking rate biased? Evidence from the second national health and nutrition examination survey. J Clin Epidemiol. 1995;48(10):1225-1233.
18. Secker-Walker RH, Vacek PM, Flynn BS, Mead PB. Exhaled carbon monoxide and urinary cotinine as measures of smoking in pregnancy. Addict Behav. 1997;22(5):671-684.
19. Campbell E, Sanson-Fisher R, Walsh R. Smoking status in pregnant women: assessment of self-report against carbon monoxide (CO). Addict Behav. 2001;26(1):1-9.
20. Monninkhof E, Valk P van der, Palen J van der, et al. The effect of a minimal contact smoking cessation programme in out-patients with chronic obstructive pulmonary disease: A pre-post-test study. Patient Educ Couns. 2004;52(3):231-236.
21. SRNT Subcommittee on Biochemical Verification. Biochemical verification of tobacco use and cessation. Nicotine Tob Res. 2002; 4(2):149-159.
22. Jarvis MJ, Tunstall-Pedoe H, Feyerabend C, Vesey C, Saloojee Y. Comparison of tests used to distinguish smokers from nonsmokers. Am J Public Health. 1987;77(11):1435-1438.
23. Benowitz NL, Kuyt F, Jacob P, Jones RT, Osman AL. Cotinine disposition and effects. Clin Pharmacol Ther. 1983;34(5):604-611.
24. Murray RP, Connett JE, Lauger GG, Voelker HT. Error in smoking measures: Effects of intervention on relations of cotinine and carbon monoxide to self-reported smoking. Am J Public Health. 1993;83(9): 1251-1257.
25. Hilberink SR, Jacobs JE, Bottema BJAM, Vries H de, Grol RPTM. Smoking cessation in patients with COPD in daily general practice (SMOCC): Six months' results. Prev Med. 2005;41(5-6):822-827.
26. Hilberink SR, Jacobs JE, Schlösser M, Grol RPTM, de Vries H. Characteristics of patients with COPD in three motivational stages related to smoking cessation. Patient Educ Couns. 2006;61(3):449-457.
27. Hilberink SR, Jacobs JE, Breteler MHM, de Vries H, Grol RPTM. General practice counseling for patients with chronic obstructive pulmonary disease to quit smoking: Impact after 1 year of two complex interventions. Patient Educ Couns. 2010 Apr 27. [Epub ahead of print]
28. Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking: Toward an integrative model of change. J Consult Clin Psychol. 1983;51(3):390-395.
29. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström test for nicotine dependence: A revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991;86(9):1119-1127.
30. Lende R van der, Orie NG. The MRC-ECCS questionnaire on respiratory symptoms (use in epidemiology). Scand J Respir Dis. 1972; 53(4):218-226.
31. Benowitz NL. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev. 1996;18(2):188-204.
32. Bize R, Burnand B, Mueller Y, Rège Walther M, Cornuz J. Biomedical risk assessment as an aid for smoking cessation. Cochrane Database Syst Rev. 2009;2:CD004705.